Dr Prantik Das MBBS, MRCP, PG Dip, FRCR

Consultant Clinical Oncologist

dr-das

 

 

GMC number: 6084584

Year of qualification: MBBS 2002

Areas of Expertise:

  • Prostate, kidney, bladder, penis, oesophageal and stomach cancer
  • Neuroendocrine and lung cancer
  • Radiotherapy: 3D conformal radiotherapy, Intensity Modulated Radiotherapy along with IGRT
  • Chemotherapy, biological therapy and novel anticancer therapy

Clinic Times:

  • Tuesday and Wednesday PM

Profile:

Dr Prantik Das is a Clinical Oncologist and Honorary Assistant Professor of University of Nottingham, School of Medicine, specialising in the treatment of all urological, oesophageal, stomach, neuroendocrine and lung cancers.

After completion of his FRCR in 2013, he went for Proton Therapy Fellowship at University of Florida, USA.

He is very interested in hypofractionated radiotherapy as a means to escalate radiation dose to tumours and improve outcomes for men with locally advanced prostate cancer.

Dr Das is principal investigator (PI) in various national and international clinical trials: (STAMPEDE, SOURCE, CASSIOPE, POUT, ATLAS,  AQUARIAS, PAZO2, KEYNOTE 811, PLATFORM, SCOPE 2, RADICALS, STAR). He is chief investigator (CI) for ACES study.

He is a first author of a number of publications in peer-reviewed journals and also worked as reviewer in international journal. He has also contributed as author of Pocket Guide to Human Tumors and Cancer by CRC press USA.

 

Areas of interest:

Radiotherapy; Chemotherapy; Biological Treatment, Novel Targeted Anticancer Drug Treatment; Image Modulated Radiotherapy (IMRT); Home Chemotherapy; Prostate Cancer; Bladder Cancer; Kidney Cancer; Penis Cancer; Testis Cancer; Testicular Cancer; Stomach Cancer; neuroendocrine Cancer; lung Cancer; IMRT, IGRT, Adaptive Radiotherapy; Systemic Chemotherapy; Immunotherapy; Monoclonal Antibodies; Biological Therapy; Gastro-Intestinal Oncology; Endocrine Oncology; Urological Cancers; SABR

Research Interests:

Prostate Cancer, Radiation Therapy, Pineal Parenchymal tumours, metastatic prostate cancer, proton therapy, hypofractionated radiotherapy, SABR, Brachytherapy

http://www.researchgate.net

Professional Memberships:

  • American Society of Clinical Oncology
  • European Society of Medical Oncology
  • Royal College of Radiologist UK
  • Royal College of Physician UK​

Videos:

Hypofractionated radiotherapy for the management of prostate cancer

The benefits of using patient reported outcomes in prostate cancer

The benefits of using patient reported outcomes in prostate cancer

Declaration:

Dr Prantik Das works with the following private medical insurance providers:

  • Aviva Health
  • AXA PPP International
  • AXA PPP Healthcare
  • Bupa
  • Cigna
  • Vitality Health (Pru Health)

Dr Prantik Das does not hold a share or financial interest in Derby Private Health.

Dr Prantik Das does not have a share or financial interest in equipment used at Derby Private Health.

Dr Prantik Das does not hold any paid advisory role(s) at this hospital or on behalf of Derby Private Health.

To find out more or arrange a consultation, email us at dhft.privatepatients@nhs.net or call us now on 01332 785200